Introduction
Inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), is likely to result from inherited mutations in disease susceptibility genes interacting with environmental factors. Epidemiological evidence from twin studies, familial clustering and intrafamilial disease concordance suggests that IBD has a strong genetic component. 1 Estimates of the sibling relative risk s vary from 10 to 35, depending on IBD phenotype used. [2] [3] [4] [5] In the Oxford IBD genome-wide scan the greatest evidence for linkage was found on chromosome 12q. 6 Subsequently four other groups worldwide have confirmed this IBD2 linkage region [7] [8] [9] [10] (OMIM: 601458). The integrins comprise a large family of transmembrane adhesion glycoproteins, each composed of an ␣ and ␤ subunit. The ␤7 integrin gene (ITGB7) maps to the IBD2 linkage region on chromosome 12. It is an excellent candidate gene for IBD susceptibility, both because of its position and the fact that it is involved in leucocyte trafficking and recruitment to the gut. The ␣4␤7 integrin heterodimer is an adhesion molecule involved in homing of all lymphocytes to the gut and associated lymphoid tissues. Gut-homing effector cells (expressing high levels of ␣4␤7 integrin) attach directly to mucosal addressin cell adhesion molecule 1 on high endothelial venules, whilst naïve cells attach initially via L-selectin.
11 ␣E␤7 integrin is expressed on gut intraepithelial lymphocytes, which are retained in the gut by binding to the ligand E-cadherin present on epithelial cells. 12, 13 Other evidence that ITGB7 plays a key role in the development of bowel inflammation comes from animal and pharmacological studies. Monoclonal antibodies to ␣4␤7 ameliorate colitis in both the cotton top tamarin and CD45RB high CD4 + T cell reconstituted severe combined immunodeficiency syndrome (SCID) mouse models of IBD. 14, 15 Knockout mice deficient for the ␤7 integrin subunit exhibit severely impaired development of the gut associated lymphoid tissue, and attenuated immune responses against helminth infection. 16, 17 Mutations in the ␤2, ␤3 and ␤4 integrins cause leukocyte adhesion deficiency, thromboasthenia and epidermolysis bullosa respectively. [18] [19] [20] We therefore hypothesised that similar functional mutations in the ␤7 integrin gene may play a role in susceptibility to IBD. Potential mechanisms for pathological mutations include increased leukocyte ␤7 integrin expression, changes in ligand affinity and alterations in the complex integrin signalling and lymphocyte activation pathway. 21 No polymorphisms in ITGB7 have been reported, and therefore we screened all exons and the 5Ј promoter region in order to identify markers to test for association. The transmission disequilibrium test (TDT) was chosen to overcome the potential 
Results

Polymorphisms
Genomic sequence was obtained, enabling all ITGB7 exons and 1.7 kb of 5Ј promoter region to be screened for polymorphisms (primers listed in Table 1 ). Revised sequence was obtained for the 5Ј promoter region. 22, 23 Fourteen single nucleotide polymorphisms (SNPs) were identified by mutation detection and sequencing ( Table  2) . We developed genotyping assays and confirmed two potentially functional SNPs and eight intronic SNPs (Table 3) . SNP3, a histidine to tyrosine change at amino acid 672 (GenBank accession number NPF000880), results in a charge change in the region between the extracellular cysteine repeats and the transmembrane domain. SNP4, a threonine to methionine change at amino acid 200, results in a size and hydrophobicity change in the mucosal addressin cell adhesion molecule-1 binding region. 24 Two out of eight SNPs confirmed in intronic Table 2 SNPs discovered by mutation detection and sequencing sequence (SNP13 and SNP18) had allele frequencies у10%.
SNP Sequence Position
Association analysis
The two amino acid changing SNPs were genotyped in the IBD families, as we hypothesised that these may be directly disease causative. Two intronic SNPs, common in the healthy population, were also genotyped as these may represent markers in linkage disequilibrium with a true disease allele. Genotypes were available on 567 IBD trios (254 ulcerative colitis, 13 indeterminate colitis and 300 Crohn's disease) from 464 families. No significant results were obtained with SNP3 (H672Y), SNP13 or SNP18 for the IBD, UC or CD phenotype (Table 4) . Four haplotypes (Ͼ1% frequency) of the three SNPs were observed, no significant haplotype TDT results were obtained for any phenotype. No significant results were found when the multiplex and simplex families were analysed separately for the three phenotypes, and allele frequencies did not differ between affecteds and controls (data not shown). The T200M mutation was found in only two families (one of which was used for mutation detection), and equal patterns of transmission and non-transmission were observed in these families.
Discussion
Linkage analysis has localised an IBD susceptibility gene to chromosome 12q. The ITGB7 gene, within this IBD2 locus, plays a key role in the induction of intestine specific inflammation (through leukocyte recruitment and retention). We therefore sought potential disease causing mutations in this positional candidate gene, encouraged by the discovery of ␤ integrin abnormalities in other conditions.
We established genomic sequence for ITGB7, and screened the entire coding region and 5Ј region for sequence variants. We had hypothesised that altered leukocyte ITGB7 expression levels may play a role in IBD susceptibility, thus it was important to screen the actual ITGB7 promoter region for polymorphisms. As our revised 5Ј region human sequence showed homology with the mouse promoter (shown to be functional in luciferase reporter gene assays), we screened 1.7 kb for promoter polymorphisms. 25 We deliberately chose to screen parents of IBD families, who are more likely to be heterozygous for a disease allele in the case of recessive or additive inheritance and carry chromosomes with healthy as well as disease variants. Although there is some evidence that UC may play a greater role in the IBD2 locus, linkage to this region has also been observed in pure CD families. 8, 26 The existence of genetic heterogeneity may complicate gene identification in IBD, but as evidence exists for linkage of IBD2 to both UC and CD we screened families of both disease types for polymorphisms.
Although the primary aim of this study was to identify disease causing mutations (likely to be in exons or promoter/regulatory regions) SNPs within introns were also discovered. These polymorphisms, whilst unlikely to be functional, can be used as markers for potential disease alleles when linkage disequilibrium exists. Thus common intronic SNPs may be used to confirm or rule out a gene containing disease causing alleles, as observed in a study in late-onset Alzheimer disease which found evidence of association for six out of 12 SNPs spanning 40 kb around the APOE-4 susceptibility allele. 27 However, no evidence for association was observed for either coding or intronic SNPs genotyped in our study. Whilst it is possible that we may have missed a rare causative mutation in the screening of ITGB7, the data from intronic SNPs reduce this possibility and provide further evidence against ITGB7 as the IBD2 gene.
The use of a large cohort of family-based controls in association studies provides both the power to detect a true association and a test robust to population heterogeneity. Simulation studies in IBD have suggested between 500-800 triplets are necessary to identify modest risk loci. 28 The 567 IBD trios we analysed had 80% power to detect a common disease allele with a genotype relative risk of 1.5 or above. Our study, therefore, was powered to exclude a substantial role for ITGB7 polymorphisms in IBD susceptibility, although to exclude mutations of weak effect would require thousands of families. 29 The majority of ITGB7 SNPs we discovered were present at low allele frequencies (р10%) in the Caucasian healthy control population. We did not identify any common functional polymorphisms in ITGB7, despite using an efficient and powerful mutation detection method with sensitivity and specificity reported to range from 96-100%. [30] [31] [32] We were, however, unable to assess polymorphisms in as yet unknown genomic regions which may regulate ITGB7 expression.
Beta 7 integrin is likely to be central to leukocyte trafficking in other inflammatory diseases of the intestine. We have facilitated the assessment of ITGB7 as a candidate gene for gastrointestinal disease through discovery of novel polymorphisms and design of primers to screen for promoter and exonic variation. Although our study cannot completely exclude linkage disequilibrium between IBD and ITGB7 polymorphisms, ITGB7 is unlikely to be the IBD2 gene and future IBD genetic studies should concentrate on other transcripts in the chromosome 12 linkage region.
Materials and methods
Genomic sequencing
In order to optimise primer design and allow for uneven melting at the ends of DNA fragments during mutation detection, at least 50 bp of intron sequence 5Ј and 3Ј of each exon was needed. This was not available from the published ITGB7 gene structure or sequence database searches. 33 A bacterial artificial chromosome clone (482a8) was screened, using primers for the 5Ј and 3Ј untranslated region of ITGB7, from the human CITB B & C libraries (Research Genetics, Huntsville, TX, USA). Primers were designed for inverse PCR or PCR between exons. 23 PCR products were sequenced using dye terminator chemistry and standard protocols on ABI 377 sequencers. To avoid confusion we have numbered the ITGB7 exons from 1 to 16, with 1 corresponding to the 5Ј exon reported after the initial paper describing the ITGB7 gene structure. 22 Working draft sequence (GenBank accession number AC073573) containing part of ITGB7 has been recently published by the Human Genome Project, and agrees with the sequence obtained in this study.
Mutation detection
Unrelated parents of multiply affected IBD families were screened for polymorphisms in ITGB7. We screened 24 individuals from seven CD, four UC and one mixed disease family. This design has 90% power to detect alleles of Ͼ5% frequency. Nineteen primer pairs were designed to amplify all 16 exons and the 5Ј region (Table 1) . PCR fragments (size 238-898 bp) were analysed for purity by agarose gel electrophoresis, heated and slowly cooled to allow hybridisation, and injected into a denaturing high pressure liquid chromatography column (Transgenomic WAVE). 34 Optimal denaturing temperature(s) for mutation detection were calculated by experimentally determined melting curves and use of WAVEMAKER software (Transgenomic, San Jose, USA). Samples were run at several temperatures if different melting domains existed. Fragments were eluted in a triethyl ammonium acetate buffer, with a linear acetonitrile gradient (as manufacturer's protocol). PCR products showing heteroduplex traces were direct sequenced in both forward and reverse strands.
Study subjects
Northern European Caucasian patients and families were recruited from the IBD clinics in Oxford, High Wycombe, Plymouth (UK) and from UK consultant gastroenterologists. Case notes of patients were reviewed and a diagnosis of ulcerative colitis, indeterminate colitis or Crohn's disease confirmed by standard endoscopic, histopathological and radiological criteria. Questionnaires were sent to all participating family members and informed consent was obtained. Ethical approval for this study was obtained from the Central Oxford Research Ethics Committee. Genotypes were obtained for 567 trios (both parents and affected child) from 102 multiply affected families (ascertained as affected sibling pairs) and 362 simplex families (one affected child only). Ninety Caucasian healthy controls were recruited from staff of the Wellcome Trust Centre for Human Genetics and Oxford hospitals.
Genotyping
Genomic DNA was extracted from peripheral blood leukocytes and quantified by fluorometric assay. Restriction enzyme digestion assays were designed using the MIS-MATCH program. 35 PCR products were digested and restriction fragment length polymorphisms analysed by agarose gel electrophoresis (assay conditions available on request). Allele frequencies were established in a panel of 90 healthy controls. Potentially functional polymorphisms, and any other polymorphisms of frequency у10% were genotyped in the simplex and multiplex families. Common intronic polymorphisms, although unlikely to be directly disease causing, may act as markers when in linkage disequilibrium with a true disease causing allele. Mendelian inheritance within each family was checked.
Mutation detection and genotyping reactions were carried out using 20 ng genomic DNA, 10 pM each forward and reverse primer, Amplitaq Gold, PCR buffer II (Applied Biosystems, Warrington, UK) and 2.5 mM Mg ++ per reaction. Annealing temperatures and number of cycles were optimised for each primer pair.
Analysis
The TDT measures transmission of a marker allele to affected offspring from parents who are heterozygous for the allele. 36 The transmitted and non-transmitted alleles are compared by a standard chi-squared test. In contrast to the case-control association study (where cases and controls are unrelated) the TDT uses internal controls from each family tested. This provides a more robust association test, unaffected by population stratification. We estimated that 244 TDT trios were needed to have 80% power to detect association (assuming significance P = 0.05, a multiplicative model, minor allele frequency у10%, genotype relative risk 2.0). 37, 38 ASPEX was used to calculate a classical TDT using both parents and one or more affected probands. 36 This test has properties of both linkage and association if multiple affected siblings are used from the same family. To make the tests of association independent of any linkage present, the level of significance was calculated empirically using simulation. 39 Multiple markers were analysed for association with an unbiased haplotype TDT, corrected for multiple affected siblings. 40 Analyses were performed for CD, UC and combined IBD phenotypes. Standardized disequilibrium coefficents (DЈ) were calculated from the combined Genes and Immunity families using Simwalk2 and the GOLD software package. 41 
